Fitbit’s PTAB Challenge to Health-Monitoring Patent Revived

The Federal Circuit remanded parts of Fitbit Inc.‘s challenge to a health-monitoring patent to the Patent Trial and Appeal Board Wednesday after finding errors in the board’s patent validity analysis.

The court also ruled that Fitbit could appeal the ruling even though it wasn’t the party that originally challenged the relevant parts of the patent.

The appeals court affirmed Fitbit’s successful challenges to three other Valencell patents in September.

Apple Inc. originally petitioned the PTAB to cancel claims 1–13 of Valencell Inc.'s U.S. Patent No. 8,923,941, covering “systems for obtaining and monitoring information such as blood oxygen level, heart ...